- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
N-(1-Oxohexadecyl) -L-glutaMic Acidum tert-Butyl Ester
Product Name:N-(1-Oxohexadecyl) -L-glutaMic Acidum tert-Butyl Ester
Formulae hypotheticae: C25H47NO5
Molecular pondus:441.64
CAS Registry Number: 536721-25-2
Fmoc-Lys(Pal-Glu-OtBu)-OH
Product Name:Fmoc-Lys(Pal-Glu-OtBu)-OH
Formulae hypotheticae: C46H69N3O8
Pondus hypotheticum: 792.06
CAS Registry Number: 1491158-62-3
(S) -22-
Product Name:(S)-22-(Tert-butoxycarbonyl) -10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontaneum-1,41-dioicum acidum
Formulae hypotheticae: C43H79N3O13
Molecular pondus:846.1
CAS Registry Number: 1118767-16-0
![Fmoc-L-Lys[Oct-(otBu)Glu-(otBu)-AEEA-AEEA]-OH](/upload/6698/fmoc-l-lys-oct-otbu-glu-otbu-aeea-aeea-oh_53149.gif "Fmoc-L-Lys[Oct-(otBu)Glu-(otBu)-AEEA-AEEA]-OH")
Fmoc-L-Lys[Oct-(otBu)Glu-(otBu)-AEEA-AEEA]-OH
Product Name:Fmoc-L-Lys[Oct-(otBu)Glu-(otBu)-AEEA-AEEA]-OH
Formulae hypotheticae: C64H101N5O16
Molecular pondus:1196.51
CAS Registry Number: 1662688-20-1
6-Hydroxypurine
Product nomen: VI-Hydroxypurine
Formulae hypotheticae: C5H4N4O
Molecular pondus:136.11
CAS Subcriptio Number: 68-94-0
![(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylaminum]-2-(4-hydroxyphenyl)acidi acetici](/upload/6698/-2r-2-4-ethyl-2-3-dioxopiperazinyl-carbonylamino-2-4-hydroxyphenyl-acetic-acid_491988.gif "(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylaminum]-2-(4-hydroxyphenyl)acidi acetici")
(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylaminum]-2-(4-hydroxyphenyl)acidi acetici
Product Name:(2R)-2-[(4-Ethyl-2,3-dioxopiperazinyl)carbonylaminum]-2-(4-hydroxyphenyl)acidi acetici
Formulae hypotheticae: C15H17N3O6
Pondus hypotheticum: 335.32
CAS Subcriptio Number:62893-24-7
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
